Recruiting Phase 1 2024-517746-34-00

A phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers

Phase 1 – testing safety in a small group of people

Conditions: Advanced breast cancer and advanced NSCLC

Sponsor: Novartis Pharma AG

trial.available_in:

БГ

Overview

Trial status: Authorised

Who can participate

Age group: 18-64 years, 65+ years Gender: Female, Male Target enrollment: 36 participants

Netherlands (1)

Status

Recruiting

Phase

Phase 1

Study type

INTERVENTIONAL

Sex

Male and female

Minimum age

18 Years

Healthy volunteers

Start date

03.07.2025

Registry ID

2024-517746-34-00

Source

euclinicaltrials.eu

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.